{{Rsnum
|rsid=247616
|Chromosome=16
|position=56955678
|Orientation=plus
|GMAF=0.2507
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 42.2 | 40.6 | 17.2
| HCB | 69.2 | 28.2 | 2.6
| JPT | 71.8 | 28.2 | 0.0
| YRI | 60.7 | 35.7 | 3.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 69.2 | 28.2 | 2.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20838585
|Trait=None
|Title=Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa Heart Study
|RiskAllele=T
|Pval=1E-23
|OR=2.99
|ORtxt=[2.42-3.56] % SD increase
|OA=1
}}
{{PMID Auto GWAS
|PMID=22003152
|Trait=None
|Title=Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
|RiskAllele=T
|Pval=3E-8
|OR=0.0230
|ORtxt=None
|OA=1
}}{{PMID|20339536|OA=1
}} Genome-wide association of lipid-lowering response to statins in combined study populations.{{PMID Auto
|PMID=23404648
|Title=An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease.
|OA=1
}}